JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Laak, J A W M
Right arrow Articles by Hanselaar, A G J M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Laak, J A W M
Right arrow Articles by Hanselaar, A G J M
Right arrowPubmed/NCBI databases
*Substance via MeSH
Journal of Clinical Pathology 2002;55:446-451
© 2002 Journal of Clinical Pathology


ORIGINAL ARTICLE

The effect of Replens® on vaginal cytology in the treatment of postmenopausal atrophy: cytomorphology versus computerised cytometry

J A W M van der Laak1, L M T de Bie2, H de Leeuw1, P C M de Wilde1, A G J M Hanselaar1

1 Department of Pathology, University Medical Center, St Radboud, PO Box 9101, 6500 HB Nijmegen, The Netherlands
2 Diagnostic Center Eindhoven, Stratumsedijk 28A, 5611 NE Eindhoven, The Netherlands

Correspondence to:
Dr J A W M van der Laak, Department of Pathology 437 PA, University Medical Center, St Radboud, PO Box 9101, 6500 HB Nijmegen, The Netherlands;
J.vanderlaak{at}pathol.azn.nl Background: After the menopause decreased concentrations of oestrogen may result in insufficient maturation of the vaginal epithelium, which can lead to a range of vaginal discomforts. This state of vaginal atrophy may be treated with oestrogen replacement treatment. ReplensTM, a non-hormonal alternative to oestrogen replacement treatment has been shown to be effective in relieving symptoms related to vaginal atrophy in previous studies.

Aims: To study the effect of Replens on the maturation of the vaginal epithelium and morphology of the vaginal cells and to compare the results of a recently developed cytomorphometric method with manual assessment of the degree of maturation in vaginal smears.

Methods: Vaginal smears from 38 postmenopausal women suffering from symptoms related to vaginal atrophy were analysed manually and by cytomorphometry. The maturation value (MV) and the percentages of (para)basal, intermediate, and superficial cells (maturation index; MI) were measured by both methods before and after treatment with Replens. Cytomorphometry also measured mean cellular area, mean nuclear area, and mean area ratio.

Results: A correlation was shown between the two methods in the assessment of percentages of (para) basal and intermediate cells and MV. Cytomorphometric data showed a significant increase in mean cellular area, indicating a positive effect of Replens on the maturation of the vaginal epithelium. Changes in nuclear area and ratio between nuclear and cellular areas were not significant. Treatment with Replens did not influence MI or MV, as assessed by the two methods.

Conclusions: Replens did have an effect on vaginal morphology. The automated procedure may be useful for the assessment of maturation in vaginal smears and is more sensitive to small (subvisual) changes.


Keywords: postmenopausal atrophy; vaginal maturation; maturation index; automated image analysis

Abbreviations: CMA, cytomorphometric analysis; H&E, haematoxylin and eosin; I, intermediate cells; MI, maturation index; MV, maturation value; P, (para)basal cells; S, superficial cells




This article has been cited by other articles:


Home page
The OncologistHome page
M. Trinkaus, S. Chin, W. Wolfman, C. Simmons, and M. Clemons
Should Urogenital Atrophy in Breast Cancer Survivors Be Treated with Topical Estrogens?
Oncologist, March 1, 2008; 13(3): 222 - 231.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.